240 related articles for article (PubMed ID: 37005644)
1. Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays.
Bellomo G; Paciotti S; Concha-Marambio L; Rizzo D; Wojdaƚa AL; Chiasserini D; Gatticchi L; Cerofolini L; Giuntini S; De Luca CMG; Ma Y; Farris CM; Pieraccini G; Bologna S; Filidei M; Ravera E; Lelli M; Moda F; Fragai M; Parnetti L; Luchinat C
Mol Neurodegener; 2023 Apr; 18(1):20. PubMed ID: 37005644
[TBL] [Abstract][Full Text] [Related]
2. Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies.
Huang J; Yuan X; Chen L; Hu B; Wang H; Wang Y; Huang W
Exp Gerontol; 2024 Mar; 187():112366. PubMed ID: 38280659
[TBL] [Abstract][Full Text] [Related]
3. Seed amplification assays for diagnosing synucleinopathies: the issue of influencing factors.
Bellomo G; Paciotti S; Gatticchi L; Rizzo D; Paoletti FP; Fragai M; Parnetti L
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1075-1088. PubMed ID: 34856754
[No Abstract] [Full Text] [Related]
4. Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort.
Concha-Marambio L; Weber S; Farris CM; Dakna M; Lang E; Wicke T; Ma Y; Starke M; Ebentheuer J; Sixel-Döring F; Muntean ML; Schade S; Trenkwalder C; Soto C; Mollenhauer B
Mov Disord; 2023 Apr; 38(4):567-578. PubMed ID: 36781413
[TBL] [Abstract][Full Text] [Related]
5. α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward.
Bellomo G; De Luca CMG; Paoletti FP; Gaetani L; Moda F; Parnetti L
Neurology; 2022 Aug; 99(5):195-205. PubMed ID: 35914941
[TBL] [Abstract][Full Text] [Related]
6. High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
Russo MJ; Orru CD; Concha-Marambio L; Giaisi S; Groveman BR; Farris CM; Holguin B; Hughson AG; LaFontant DE; Caspell-Garcia C; Coffey CS; Mollon J; Hutten SJ; Merchant K; Heym RG; Soto C; Caughey B; Kang UJ
Acta Neuropathol Commun; 2021 Nov; 9(1):179. PubMed ID: 34742348
[TBL] [Abstract][Full Text] [Related]
7. Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson's disease.
Bongianni M; Catalan M; Perra D; Fontana E; Janes F; Bertolotti C; Sacchetto L; Capaldi S; Tagliapietra M; Polverino P; Tommasini V; Bellavita G; Kachoie EA; Baruca R; Bernardini A; Valente M; Fiorini M; Bronzato E; Tamburin S; Bertolasi L; Brozzetti L; Cecchini MP; Gigli G; Monaco S; Manganotti P; Zanusso G
Transl Neurodegener; 2022 Jul; 11(1):37. PubMed ID: 35902902
[TBL] [Abstract][Full Text] [Related]
8. Toward the quantification of α-synuclein aggregates with digital seed amplification assays.
Gilboa T; Swank Z; Thakur R; Gould RA; Ooi KH; Norman M; Flynn EA; Deveney BT; Chen A; Borberg E; Kuzkina A; Ndayisaba A; Khurana V; Weitz DA; Walt DR
Proc Natl Acad Sci U S A; 2024 Jan; 121(3):e2312031121. PubMed ID: 38194461
[TBL] [Abstract][Full Text] [Related]
9. Comparison of biospecimens for α-synuclein seed amplification assays in Parkinson's disease: A systematic review and network meta-analysis.
Zheng Y; Li S; Yang C; Yu Z; Jiang Y; Feng T
Eur J Neurol; 2023 Dec; 30(12):3949-3967. PubMed ID: 37573472
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
Poggiolini I; Gupta V; Lawton M; Lee S; El-Turabi A; Querejeta-Coma A; Trenkwalder C; Sixel-Döring F; Foubert-Samier A; Pavy-Le Traon A; Plazzi G; Biscarini F; Montplaisir J; Gagnon JF; Postuma RB; Antelmi E; Meissner WG; Mollenhauer B; Ben-Shlomo Y; Hu MT; Parkkinen L
Brain; 2022 Apr; 145(2):584-595. PubMed ID: 34894214
[TBL] [Abstract][Full Text] [Related]
11. Conformational change of α-synuclein fibrils in cerebrospinal fluid from different clinical phases of Parkinson's disease.
Fan Y; Sun Y; Yu W; Tao Y; Xia W; Liu Y; Zhao Q; Tang Y; Sun Y; Liu F; Cao Q; Wu J; Liu C; Wang J; Li D
Structure; 2023 Jan; 31(1):78-87.e5. PubMed ID: 36513068
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders.
Fernandes Gomes B; Farris CM; Ma Y; Concha-Marambio L; Lebovitz R; Nellgård B; Dalla K; Constantinescu J; Constantinescu R; Gobom J; Andreasson U; Zetterberg H; Blennow K
Parkinsonism Relat Disord; 2023 Dec; 117():105807. PubMed ID: 37591709
[TBL] [Abstract][Full Text] [Related]
13. Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis.
Gadhe L; Sakunthala A; Mukherjee S; Gahlot N; Bera R; Sawner AS; Kadu P; Maji SK
Biophys Chem; 2022 Feb; 281():106736. PubMed ID: 34923391
[TBL] [Abstract][Full Text] [Related]
14. Detection of α-Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder.
Zheng Y; Yu Z; Cai H; Kou W; Yang C; Li S; Zhang N; Feng T
Mov Disord; 2024 May; ():. PubMed ID: 38715177
[TBL] [Abstract][Full Text] [Related]
15. The promise of amplification assays for accurate early detection of α-synucleinopathies: A review.
Kurapova R; Chouliaras L; O'Brien JT
Exp Gerontol; 2022 Aug; 165():111842. PubMed ID: 35623540
[TBL] [Abstract][Full Text] [Related]
16. Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification.
Mammana A; Baiardi S; Rossi M; Quadalti C; Ticca A; Magliocchetti F; Bernhardt A; Capellari S; Parchi P
Clin Chem Lab Med; 2024 Mar; ():. PubMed ID: 38456740
[TBL] [Abstract][Full Text] [Related]
17. Detection of skin α-synuclein using RT-QuIC as a diagnostic biomarker for Parkinson's disease in the Chinese population.
Li J; Duan S; Yang J; Zheng H; Yuan Y; Tang M; Wang Y; Liu Y; Xia Z; Luo H; Xu Y
Eur J Med Res; 2024 Feb; 29(1):114. PubMed ID: 38336827
[TBL] [Abstract][Full Text] [Related]
18. Brain and Cerebrospinal Fluid α-Synuclein Real-Time Quaking-Induced Conversion Identifies Lewy Body Pathology in LRRK2-PD.
Garrido A; Fairfoul G; Tolosa E; Marti MJ; Ezquerra M; Green AJE
Mov Disord; 2023 Feb; 38(2):333-338. PubMed ID: 36471633
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid-A Systematic Review and Meta-Analysis.
Grossauer A; Hemicker G; Krismer F; Peball M; Djamshidian A; Poewe W; Seppi K; Heim B
Mov Disord Clin Pract; 2023 May; 10(5):737-747. PubMed ID: 37205253
[TBL] [Abstract][Full Text] [Related]
20. A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research.
Kumar ST; Donzelli S; Chiki A; Syed MMK; Lashuel HA
J Neurochem; 2020 Apr; 153(1):103-119. PubMed ID: 31925956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
